| Issue |
BIO Web Conf.
Volume 229, 2026
The 3rd International Conference of Advanced Veterinary Science and Technologies for Sustainable Development (3rd ICAVESS 2025)
|
|
|---|---|---|
| Article Number | 03002 | |
| Number of page(s) | 7 | |
| Section | Managing Emerging Diseases | |
| DOI | https://doi.org/10.1051/bioconf/202622903002 | |
| Published online | 12 March 2026 | |
Polyclonal antibody production against recombinant Staphylococcal Enterotoxin A (rSEA) derived from a dairy mastitis isolate
1 Department of Clinical Pathology, Faculty of Veterinary Medicine, Gadjah Mada University, Yogyakarta, Indonesia
2 Department of Bioresources Technology and Veterinary, Vocational College, Gadjah Mada University, 55281, Yogyakarta, Indonesia
* Corresponding author: This email address is being protected from spambots. You need JavaScript enabled to view it.
Abstract
Staphylococcal enterotoxin A (SEA) is one of the most prevalent toxins associated with staphylococcal food poisoning. However, only a few diagnostic methods provide adequate sensitivity and specificity for SEA detection. In this study, Staphylococcus aureus isolated from a dairy mastitis cow (strain FKH 182) was analyzed by polymerase chain reaction (PCR) and confirmed to carry the sea gene (127 bp). The SEA gene fragment encoding the mature peptide was amplified, cloned, sequenced, and inserted into a pET22b expression vector. The recombinant SEA (rSEA) protein was expressed as a hexahistidine-tagged fusion protein in Escherichia coli BL21 (DE3). Purified rSEA was then used to generate polyclonal antibodies (pAb) in Balb/c mice. Indirect enzyme-linked immunosorbent assay (ELISA) demonstrated that the anti-rSEA pAb reached a titer of 1:3200 at 59 days post-immunization. Western blotting confirmed the specificity of the antibody with a distinct band at approximately 30 kDa. Furthermore, the polyclonal antibody was applied in antigen capture-ELISA (AC-ELISA) to detect SEA in 50 human clinical Staphylococcus aureus isolates, with diagnostic sensitivity and specificity of 0.80 and 0.91, respectively, compared with PCR. These findings indicate that recombinant SEA is a reliable immunogen for pAb production and that the developed pAb can be applied as a practical tool for large-scale detection of SEA in clinical and food safety investigations.
© The Authors, published by EDP Sciences, 2026
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.

